Delivery Order SPE2DB20D2014-SPE2DB24FC47T
Award Date
7/15/24
Potential Completion Date
7/16/24
Potential Value
$7.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,652,155 units of Ondansetron HCL 8 mg tablets. The firm-fixed-price delivery order, valued at $3,711.94, has a period of performance through November 1, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of 4,565,470,676 units of Ondansetron HCL 8 mg tablets by Amerisourcebergen Drug Corp to the U.S. government. The contract, valued at $7,519.33, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued up to $999,999,999 through December 2025, enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies from...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,817.62 Firm Fixed Price Delivery Order is for the supply of 4,563,265,608 units of Ondansetron HCL 8 mg Tablets in 30-count packages. The contract has a period of performance through January 9, 2024 and does not include any set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $5,229.49 firm fixed-price Delivery Order is for the supply of 4,564,742,877 units of Ondansetron Hydrochloride 8 mg tablets, with a completion date of May 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $4,415.28, is for the delivery of 4,563,893,893 units of the medication Ondansetron HCL 8 mg tablets. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,914.83 delivery order contract is for the supply of 4,566,188,517 units of 8 mg Ondansetron HCL tablets, with a period of performance ending on October 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,121.20 delivery order contract is for the supply of 4,568,160,360 units of Ondansetron HCL 8 mg tablets. The contract is a firm fixed-price, non-set-aside agreement with a performance period through May 7, 2025. Amerisourcebergen Drug Corp is the prime contractor and there are no subcontractors referenced. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,310 units of Ondansetron hydrochloride 8 mg tablets. The contract has a firm fixed price of $17,144.53 and a completion date of August 1, 2024. The award is not designated as a set-aside contract. Amerisourcebergen's Corporate Office division is responsible for fulfilling this delivery order, which is part of a larger...
This contract award is a Delivery Order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,726.08 Firm Fixed Price contract is for the supply of 4,565,255,957 units of Ondansetron HCL 8 mg tablets. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
The U.S. government agency Defense Logistics Agency (DLA) awarded a $12,102.52 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,287,347 units of Ondansetron ODT 8 mg Tablets. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company...